表紙:吸入麻酔薬の世界市場
市場調査レポート
商品コード
913402

吸入麻酔薬の世界市場

Inhalation Anesthetics

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 125 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
吸入麻酔薬の世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 125 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の吸入麻酔薬市場を調査し、市場の概要、セグメント(亜酸化窒素、ハロゲン化麻酔薬)、需要動向、売上額の推移と予測、市場の成長要因、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 注目企業
  • 市場動向と成長要因
  • 世界市場の見通し

第3章 市場分析

  • 地域市場の分析
  • 米国
    • 市場概要
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他の欧州諸国
  • アジア太平洋地域
  • その他の地域

第4章 競合情勢

  • ABBVIE
  • BAXTER & SONS
  • LUNAN PHARMACEUTICALS
  • PIRAMAL CRITICAL CARE

第5章 調査資料

目次
Product Code: MCP12727

Abstract:

Global Inhalation Anesthetics Market to Reach $1.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Inhalation Anesthetics estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at aCAGR of 3.3% over the period 2020-2027. Nitrous Oxide, one of the segments analyzed in the report, is projected to record 3.5% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Halogenated Agents segment is readjusted to a revised 2.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $354.5 Million, While China is Forecast to Grow at 3.2% CAGR

The Inhalation Anesthetics market in the U.S. is estimated at US$354.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$270 Million by the year 2027 trailing a CAGR of 3.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 2.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Select Competitors (Total 41 Featured) -

  • Abbott
  • AbbVie Inc.
  • Baxter
  • Eisai
  • Fresenius Kabi AG
  • Halocarbon Products Corporation
  • Hikima Pharmaceuticals plc.
  • Jiangsu Hengrui Medicine Co. Ltd.
  • Lunan Pharmaceutical Group Co. Ltd
  • Mylan
  • Piramal Enterprises Limited

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Inhalation Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Inhalation Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Inhalation Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Nitrous Oxide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Nitrous Oxide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Nitrous Oxide by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Halogenated Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Halogenated Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Halogenated Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 10: USA Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 11: USA Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: USA 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 13: Canada Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 14: Canada Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: Canada 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 16: Japan Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 17: Japan Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: Japan 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 19: China Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 20: China Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: China 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 22: Europe Current & Future Analysis for Inhalation Anesthetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: Europe Historic Review for Inhalation Anesthetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: Europe 15-Year Perspective for Inhalation Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 25: Europe Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Europe Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: Europe 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 28: France Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: France Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: France 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 31: Germany Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Germany Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: Germany 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 34: Italy Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Italy Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Italy 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 37: UK Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: UK Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: UK 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 40: Rest of Europe Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Rest of Europe Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Rest of Europe 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 43: Asia-Pacific Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Asia-Pacific Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Asia-Pacific 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 46: Rest of World Current & Future Analysis for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Rest of World Historic Review for Inhalation Anesthetics by Segment - Nitrous Oxide and Halogenated Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Rest of World 15-Year Perspective for Inhalation Anesthetics by Segment - Percentage Breakdown of Value Sales for Nitrous Oxide and Halogenated Agents for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 41